Wednesday 20th June 2018
|Text too small?|
Comvita said it has acquired 20 percent of Uruguay's Apiter for US$6.25 million and signed a long-term supply agreement to secure another source of propolis for sales into Asia.
The purchase price is comprised of US$5.65 million in cash and milestone earnouts and US$600,000 of Comvita shares, with settlement due on July 2, Te Puke-based Comvita said in a statement. Propolis is made by bees from plant resins to protect and sterilise their hives.
“We have always been supply-constrained for New Zealand sourced propolis," said chief executive Scott Coulter. "Together with a long-term supply agreement, the investment in Apiter removes our supply constraints for this key ingredient platform. Although this investment is not material from a group earnings perspective in the short term, it underpins our long-term strategy of this business segment.
"While relatively unknown in New Zealand, propolis and its health properties are well understood, with a high level of consumer awareness throughout many Asian markets," he said. "Particularly in China, we sell a large range of propolis capsules, tablets, soft gels, tinctures and toothpastes.”
Last month Comvita said it had ended talks with a party that had been undertaking due diligence with the intention of making a full or partial takeover of the New Zealand company.
In April, the company slashed its forecast for after-tax operating profit to a range of $8 million-to-$11 million for the year ending June 30, down from an earlier forecast for earnings of more than $17.1 million due to the poor honey harvest.
Comvita shares fell 0.2 percent to $5.73 and have gained 6 percent in the past 12 months, lagging behind a 17 percent gain in the S&P/NZX 50 Index.
No comments yet
MARKET CLOSE: NZ shares gain as upcoming Fed meeting bolsters yield stocks; Sky TV gains
ESW reaches 90% of SLI Systems, moves to compulsory acquisition
NZ higher against USD as markets await the US Federal Reserve
Hawke's Bay council advances Napier Port IPO plan
Government outlines planned hikes in minimum wage
Chorus could lift its dividend post-UFB rollout but risks remain
T&G Global profit dented by cheaper tomatoes, small grape harvest
NZ posts widest current account deficit since 2009, in line with expectations
Heartland says new bank capital rules won't hurt as much as the market thinks
ISS supports Vital Healthcare's rebel investors